October was a big month for stocks. It was one of the best ever for the S&P 500 Index.
As my colleague Brett Eversole explained recently in DailyWealth, that means more gains are likely ahead. And sure enough, November has been another strong month for stocks, even if things have been shaky in recent days.
But it's not just the overall market that has done well...
The Nasdaq 100 Index had a huge October too, rising 7.9%. It's positive by around 2% in November. And even more, this basket of tech stocks is coming off a hot streak.
It recently strung together 10 up days in a row. This is a major sign of strength for the sector. Investors have been driving the market higher, day after day.
Importantly, this signals more upside in tech stocks from here. Let me explain...
The Nasdaq 100 holds the 100 largest stocks from the Nasdaq Composite Index. And as I said, it recently rallied for 10 consecutive days.
That might seem like a random coincidence... something to notice, but not to think much about. But history tells us that's not the case.
When an investment rallies day in and day out, it means the trend is strong. More than that, it means the trend is accelerating. And we can see that the recent breakout will likely lead to more gains...
Since 1990, there have been 26 similar up-day setups in the Nasdaq 100 Index. And buying after those setups has led to winning trades 93% of the time.
Importantly, we're coming off one of these right now. It happened at the end of October, as you can see below...
History shows this is an indicator worth paying attention to.
Since 1990, the Nasdaq 100 Index has done incredibly well – returning 15% per year. But setups like today's have led to even better results...
You can see in the table above that both strategies have led to gains of about 7% in six months. But buying after up-day setups outperforms a basic buy-and-hold strategy in the long term...
Similar cases have led to 20% gains over the next year... with a 93% win rate, as I explained earlier. You can see all of the outperformance happens in the full-year return.
Stocks have been rocky in recent days. But the long-term trend is still firmly up. And in the case of the Nasdaq, we'll likely see big gains over the next year.
The tech-heavy Nasdaq 100 rallied for 10 straight days last month. It could lead to 20% gains over the next year. And that means investors should strongly consider owning this part of the market right now.
Good investing,
Chris Igou
Further Reading
Melt Downs always follow booms like the one we're seeing today. And while one will certainly arrive at some point, it's not likely to happen in the near future. That means stocks could rocket even higher... Read more here: Why I No Longer Expect a Market Crash This Year.
"Most investors see new highs and get caught up in strong emotions," Brett Eversole says. But strong emotions can often serve as a contrarian indicator. In fact, history says we could see stock prices soar even higher in the near future... Learn more here: Don't Bet Against Stocks at New Highs.
Tech stocks are likely to soar even higher in 2022. And as this sector takes off, it could also lead to a boom in this cybersecurity company...
THIS BIG PHARMA GIANT IS SAVING LIVES AND BOOSTING PROFITS
Today, we're looking at one of the biggest names in the health care industry...
DailyWealth readers know Dr. David Eifrig has long been bullish on health care. You see, more than 70 million Baby Boomers will be age 65 or older by 2030. And as folks age, they need more treatments and medicines... So health care stocks stand to see huge gains. Today's company is already benefiting...
Pfizer (PFE) is a $305 billion pharmaceutical giant. It owns many lifesaving drugs that are crucial to seniors, such as Eliquis (for treating blood clots and preventing strokes) and Vyndamax (for treating heart failure). It has also been one of the biggest players in the fight against COVID-19 – having shipped 2 billion doses of its COVID-19 vaccine to more than 150 countries. So it's no wonder the company is succeeding today... In the most recent quarter, total revenue was up 134% year over year to $24.1 billion.
PFE shares have steadily climbed higher over the past year. They are up roughly 40% and recently hit a new all-time high. As long as Pfizer keeps leading the health care industry, we can expect this uptrend to continue...
